deltatrials
Completed PHASE3 NCT00136864

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)

Sponsor: Ontario Clinical Oncology Group (OCOG)

Conditions Non-Small-Cell Lung Carcinoma
Interventions PET Diagnostic Imaging
Updated 5 times since 2017 Last updated: Nov 17, 2011 Started: Aug 31, 2004 Primary completion: Nov 30, 2009 Completion: Sep 30, 2011

A PHASE3 clinical study on Non-Small-Cell Lung Carcinoma, this trial is completed. The trial is conducted by Ontario Clinical Oncology Group (OCOG) and has accumulated 5 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ontario Clinical Oncology Group (OCOG)
  • Ontario Ministry of Health and Long Term Care
Data source: Ontario Clinical Oncology Group (OCOG)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations